The pivotal Phase 3 trial with BNT323/DB-1303 follows positive Phase 1/2 safety and efficacy data in patients with Human Epidermal Growth Factor Receptor 2 (“HER2”)-expressing advanced solid tumors ...
KRYTAR, Inc., a leader in the design and production of ultra-broadband microwave components and test equipment announces two new 180-Degree Hybrid Couplers that deliver 3 dB of coupling over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback